Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Erin E. Stevens"'
Publikováno v:
Palliative Care and Social Practice, Vol 18 (2024)
Advance care planning (ACP) supports individuals in aligning their medical care with personal values and preferences in the face of serious illness. The variety of ACP tools available reflects diverse strategies intended to facilitate these critical
Externí odkaz:
https://doaj.org/article/2b58eaf716164f0fa0931e38d0a30056
Proof of principle study of sequential combination atezolizumab and Vigil in relapsed ovarian cancer
Autor:
Luisa Manning, Bradley J. Monk, Phylicia Aaron, Evanthia Galanis, Staci Horvath, Rodney P. Rocconi, Thomas J. Herzog, Erin E. Stevens, Adnan R. Munkarah, Meghan Manley, Sharad A. Ghamande, Justin N. Bottsford-Miller, Gladice Wallraven, John Nemunaitis, Adam Walter, Robert L. Coleman, Jeffrey Elder, Leslie L. DeMars, Laura Stanbery, Ernest Bognar
Publikováno v:
Cancer Gene Therapy. 29:369-382
Vigil® is a personalized vaccine that enhances tumor neoantigen expression. We investigated for the first time safety and efficacy of Vigil in combination with atezolizumab in relapsed ovarian cancer (OC) patients. This is a randomized, Phase 1 stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0220c0e11bf3dd7327de5fed5f7a2d3b
https://doi.org/10.1038/s41417-021-00317-5
https://doi.org/10.1038/s41417-021-00317-5
Autor:
Minal A. Barve, Devansu Tewari, Rodney P. Rocconi, Justin Bottsford-Miller, Gladice Wallraven, Laura Stanbery, John Nemunaitis, Bradley J. Monk, Brian M. Slomovitz, Peter C. Morris, Robert L. Coleman, Thomas J. Herzog, Phylicia Aaron, David M. Shanahan, Jonathan C. Oh, Erin E. Stevens, Elizabeth A. Grosen, John K. Chan, Staci Horvath, Sharad A. Ghamande, Luisa Manning, Ernest Bognar, Min Tang
Publikováno v:
The Lancet Oncology. 21:1661-1672
Summary Background Gemogenovatucel-T is an autologous tumour cell vaccine manufactured from harvested tumour tissue, which specifically reduces expression of furin and downstream TGF-β1 and TGF-β2. The aim of this study was to determine the safety
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5f8cb1c5ab1c279408411411ca87bc5
https://doi.org/10.1016/s1470-2045(20)30533-7
https://doi.org/10.1016/s1470-2045(20)30533-7
Proof of principle study of sequential combination atezolizumab and Vigil in relapsed ovarian cancer
Autor:
Rodney P, Rocconi, Erin E, Stevens, Justin N, Bottsford-Miller, Sharad A, Ghamande, Jeffrey, Elder, Leslie L, DeMars, Adnan, Munkarah, Phylicia, Aaron, Laura, Stanbery, Gladice, Wallraven, Ernest, Bognar, Meghan, Manley, Staci, Horvath, Luisa, Manning, Adam, Walter, Evanthia, Galanis, Thomas, Herzog, Bradley J, Monk, Robert L, Coleman, John, Nemunaitis
Publikováno v:
Cancer gene therapy. 29(3-4)
Vigil® is a personalized vaccine that enhances tumor neoantigen expression. We investigated for the first time safety and efficacy of Vigil in combination with atezolizumab in relapsed ovarian cancer (OC) patients. This is a randomized, Phase 1 stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::57f5a52dfbda042a49db503872a1c8ee
https://pubmed.ncbi.nlm.nih.gov/33753870
https://pubmed.ncbi.nlm.nih.gov/33753870
Autor:
Linda Hong, Uma Chandavarkar, Lisa Rubinsak, Yevgenia Ioffe, Erin E. Stevens, Deanna Gek Koon Teoh, Amy Brockmeyer, Sarah M. Temkin, Michelle F. Benoit
Publikováno v:
Journal of Clinical Oncology. 39:11013-11013
11013 Background: A high prevalence of gender discrimination and harassment has been described among gynecologic oncologists (GOs). This study examined the work environment for women GOs and delineated the perpetrators of negative behaviors. Methods:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00f2283ec6d20ba24ac2cf91ace07753
https://doi.org/10.1200/jco.2021.39.15_suppl.11013
https://doi.org/10.1200/jco.2021.39.15_suppl.11013
Autor:
Ernest Bognar, Robert L. Coleman, Luisa Manning, David M. O'Malley, Minal A. Barve, Sharad A. Ghamande, Erin E. Stevens, Thomas J. Herzog, Laura Stanbery, John Nemunaitis, Bradley J. Monk, Phylicia Aaron, Rodney P. Rocconi
Publikováno v:
Journal of Clinical Oncology. 39:5502-5502
5502 Background: In the VITAL (NCT02346747) trial, maintenance therapy with Vigil, an autologous tumor cell vaccine transfected with a DNA plasmid encoding GMCSF and bi-shRNA-furin for TGFβ expression control, following frontline platinum-based chem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::868998cfeaa5eafa52aa249e72930d70
https://doi.org/10.1200/jco.2021.39.15_suppl.5502
https://doi.org/10.1200/jco.2021.39.15_suppl.5502
Autor:
Bradley J. Monk, Devansu Tewari, Erin E. Stevens, Gladice Wallraven, John Nemunaitis, Luisa Manning, Jonathan Oh, Rodney P. Rocconi, John K. Chan, Sharad A. Ghamande, Justin N. Bottsford-Miller, Peter C. Morris, Thomas J. Herzog, Elizabeth A. Grosen, Phylicia Aaron, Ernest Bognar, Min Tang, Minal A. Barve, Brian M. Slomovitz, Robert L. Coleman, Vigil Team
Publikováno v:
Journal of Clinical Oncology. 38:6017-6017
6017 Background: Vigil is an autologous tumor cell vaccine constructed from autologous harvested tumor tissue transfected with a DNA plasmid encoding GMCSF and bi-shRNA-furin thereby creating TGFβ expression control. Methods: A randomized double-bli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d57902b9f63973509d4beb8cad19d60
https://doi.org/10.1200/jco.2020.38.15_suppl.6017
https://doi.org/10.1200/jco.2020.38.15_suppl.6017
Autor:
Robert L. Coleman, Vigil Team, Phylicia Aaron, Sharad A. Ghamande, Bradley J. Monk, Rodney P. Rocconi, Meghan Manley, Justin N. Bottsford-Miller, Thomas J. Herzog, Staci Horvath, Gladice Wallraven, John Nemunaitis, Ernest Bognar, Erin E. Stevens, Luisa Manning
Publikováno v:
Journal of Clinical Oncology. 38:3002-3002
3002 Background: Recent studies have shown poor clinical outcomes and limited survival advantage to checkpoint inhibitors (CIs) in advanced stage ovarian cancer (OvC). Vigil is a personalized precision vaccine constructed from autologous tumor tissue
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aea943126b39fee6d30efa3043ab7087
https://doi.org/10.1200/jco.2020.38.15_suppl.3002
https://doi.org/10.1200/jco.2020.38.15_suppl.3002
Publikováno v:
The American Cancer Society's Oncology in Practice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7790cb9c73adec28a3b0f0993bdf9a02
https://doi.org/10.1002/9781118592168.ch19
https://doi.org/10.1002/9781118592168.ch19
Autor:
Erin E. Stevens, Melanie Van Sise, Tana S. Pradhan, Vanessa Lee, Sarah Yu, Ovadia Abulafia, Michael L. Pearl, Yi-Chun Lee
Publikováno v:
Archives of Gynecology and Obstetrics. 286:1507-1512
To determine if elevated markers of poor glycemic control (HgA1c and fasting glucose levels) in patients surgically staged for type I endometrial cancer is related to a higher stage or higher grade at the time of diagnosis. Also, to assess if these m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c391a108bc80da810d679b1f33a42a07
https://doi.org/10.1007/s00404-012-2455-7
https://doi.org/10.1007/s00404-012-2455-7